Comparison of doses to OARs

A comparison of doses to OARs in inverse planned IMRT and 3D conformal prostate treatments.


B. Mzenda, P. Peters, J. Pettingell, H. Kerr, K. Walsh, A. Eve, N. McAndrew, M. Robb, S. Razaq, A. Penny


Following the recent Royal College of Radiologists (RCR) recommendations[1, 2] all prostate cancer patients at Cancer Partners UK centres are treated with inverse planned IMRT. This study compares the organ at risk (OAR) doses as well as the PTV dose distributions and irradiated volumes in IMRT and 3D conformal radiotherapy (3DCRT) treatment of prostate carcinoma.

Make an enquiry

Contact us using our online form, and we'll do what we can to help.


Download the GenesisCare deep inspiration breath-hold whitepaper.

Find a consultant

Specialist Cancer Consultant

We work with some of the UK's leading consultant surgeons, oncologists, and radiologists - find one with the expertise you need.


On 8th January 2016, we changed our name to GenesisCare.